As more Covid-19 vaccines become available in the U.S., it is getting tougher to run large clinical trials to test a new vaccine's ability to prevent disease because people are less willing to take a placebo forcing drugmakers and researchers to look for workarounds as they vet the next generation of shots and test new uses for authorized ones.
Moderna Inc won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.
(Bloomberg) Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.
Shots by AstraZeneca Plc, Pfizer Inc.-BioNTech SE and Sinovac Biotech Ltd.
Thailand Approves AstraZeneca: Southeast Asia Vaccine Tracker
Bloomberg 1/23/2021 Claire Jiao and Ian Sayson
(Bloomberg) AstraZeneca Plc’s vaccine won approval from Thailand, becoming the third company to clear regulatory requirements for use in Southeast Asia.
Thousands of people in Singapore and Indonesia have already received the Pfizer Inc.-BioNTech SE and Sinovac Biotech Ltd. vaccines, and their neighbors are signing more deals to procure supplies. China is also giving free vaccines to countries like the Philippines and Cambodia.
Indonesia, Southeast Asia’s biggest and most populous economy, started its coronavirus vaccination program on Jan. 13, with President Joko Widodo taking the first Sinovac jab as the race to immunize people against Covid-19 gains pace.
By Reuters Staff
2 Min Read
MANILA, Dec 21 (Reuters) - The Philippines expects to receive 30 million doses of Novavax Inc’s COVID-19 vaccine by July next year, its foreign minister said on Monday, boosting the country’s effort to secure supplies to inoculate more than 100 million people.
Despite consultations with numerous vaccine makers, the Philippines has so far signed only one supply deal, with the help of its private sector, to acquire 2.6 million shots of a vaccine developed by AstraZeneca.
It plans to buy 25 million doses of a vaccine from China’s Sinovac Biotech for delivery by March and aims to secure between four and 25 million doses of vaccines from Moderna and Arcturus Therapeutics Holdings Inc.